Etamivan

Source: Wikipedia, the free encyclopedia.
Etamivan
Clinical data
Trade namesAnalepticon
ATC code
Identifiers
  • N,N-Diethyl-4-hydroxy-3-methoxybenzamide
JSmol)
  • CCN(CC)C(=O)c1ccc(O)c(OC)c1
  • InChI=1S/C12H17NO3/c1-4-13(5-2)12(15)9-6-7-10(14)11(8-9)16-3/h6-8,14H,4-5H2,1-3H3 ☒N
  • Key:BQJODPIMMWWMFC-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Etamivan (

overdose[2] and chronic obstructive pulmonary disease,[3]
but has now largely fallen into disuse.

Adverse effects which are common to the respiratory stimulant class include sneezing, coughing, and

carbon dioxide narcosis in adults ranges from 0.5 mg/kg to 5.0 mg/kg, infused intravenously over several minutes. Epilepsy and the use of monoamine oxidase inhibitors or other adrenergic drugs are contraindications.[4]

References

  1. PMID 1173598
    .
  2. PMID 14000228
    .
  3. PMID 14226094
    .
  4. OCLC 1024170745
    .


drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Etamivan&oldid=1194300579"